Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Histone modification is key in treating chronic inflammatory skin diseases.

The skin microbiome helps heal wounds and can be targeted to improve healing.

Different types of inactive melanocyte stem cells exist with unique characteristics and potential to develop into other cells.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Scientists successfully grew mini hair follicles using human skin cells, which could help treat baldness.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Calcium signals and SHH guide the direction of feather growth in chicken skin.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Eating grape powder may reduce the severity of skin allergy symptoms.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

The model can effectively test gene functions and drug responses in human skin.

The summit aimed to speed up finding treatments for alopecia areata.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Hair papilla cells are crucial for blood vessel development in hair follicles, affecting hair growth and loss.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

New research is helping develop better treatments for alopecia areata.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.